NZ515355A - Cyclocarbamate derivatives as progesterone receptor modulators - Google Patents
Cyclocarbamate derivatives as progesterone receptor modulatorsInfo
- Publication number
- NZ515355A NZ515355A NZ515355A NZ51535500A NZ515355A NZ 515355 A NZ515355 A NZ 515355A NZ 515355 A NZ515355 A NZ 515355A NZ 51535500 A NZ51535500 A NZ 51535500A NZ 515355 A NZ515355 A NZ 515355A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- alkynyl
- alkenyl
- optionally substituted
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18301299P | 1999-05-04 | 1999-05-04 | |
| US09/552,633 US6509334B1 (en) | 1999-05-04 | 2000-04-19 | Cyclocarbamate derivatives as progesterone receptor modulators |
| PCT/US2000/011822 WO2000066571A1 (en) | 1999-05-04 | 2000-05-01 | Cyclocarbamate derivatives as progesterone receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ515355A true NZ515355A (en) | 2004-02-27 |
Family
ID=26878647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ515355A NZ515355A (en) | 1999-05-04 | 2000-05-01 | Cyclocarbamate derivatives as progesterone receptor modulators |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1173426A1 (zh) |
| JP (1) | JP2002543193A (zh) |
| KR (1) | KR20010114250A (zh) |
| CN (1) | CN1145618C (zh) |
| AU (1) | AU766428B2 (zh) |
| BG (1) | BG106079A (zh) |
| BR (1) | BR0010213A (zh) |
| CA (1) | CA2371726A1 (zh) |
| CZ (1) | CZ20013951A3 (zh) |
| EA (1) | EA004512B1 (zh) |
| HU (1) | HUP0201609A3 (zh) |
| IL (1) | IL146280A0 (zh) |
| MX (1) | MXPA01011286A (zh) |
| NO (1) | NO321361B1 (zh) |
| NZ (1) | NZ515355A (zh) |
| PL (1) | PL351127A1 (zh) |
| SG (1) | SG114650A1 (zh) |
| SK (1) | SK15912001A3 (zh) |
| TR (1) | TR200103286T2 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005007021D1 (de) * | 2004-04-27 | 2008-07-03 | Wyeth Corp | Cyanopyrrolhaltige cyclische carbamat- und thiocarbamatbiaryle und verfahren zu deren herstellung |
| US20100160304A1 (en) * | 2005-01-19 | 2010-06-24 | Dainippon Sumitomo Pharma Co., Ltd | Aromatic sulfone compound as aldosterone receptor modulator |
| WO2009044788A1 (ja) | 2007-10-05 | 2009-04-09 | Banyu Pharmaceutical Co., Ltd. | ベンゾオキサジノン誘導体 |
| CN111925353B (zh) * | 2020-08-31 | 2022-04-08 | 苏州大学附属第二医院 | 一种2-噻吩甲腈的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0510235A1 (en) * | 1991-04-26 | 1992-10-28 | Dong-A Pharm. Co., Ltd. | Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same |
| WO1995020389A1 (en) * | 1994-01-28 | 1995-08-03 | Merck & Co., Inc. | Benzoxazinones as inhibitors of hiv reverse transcriptase |
| PT800519E (pt) * | 1994-12-22 | 2004-03-31 | Ligand Pharm Inc | Compostos moduladores de receptores de esteroides e metodos |
| CA2268953A1 (en) * | 1996-10-02 | 1998-04-09 | Du Pont Pharmaceuticals Company | 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
-
2000
- 2000-05-01 CZ CZ20013951A patent/CZ20013951A3/cs unknown
- 2000-05-01 SG SG200400080A patent/SG114650A1/en unknown
- 2000-05-01 PL PL00351127A patent/PL351127A1/xx not_active Application Discontinuation
- 2000-05-01 EP EP00928689A patent/EP1173426A1/en not_active Withdrawn
- 2000-05-01 CA CA002371726A patent/CA2371726A1/en not_active Abandoned
- 2000-05-01 EA EA200101176A patent/EA004512B1/ru not_active IP Right Cessation
- 2000-05-01 IL IL14628000A patent/IL146280A0/xx unknown
- 2000-05-01 BR BR0010213-0A patent/BR0010213A/pt not_active Application Discontinuation
- 2000-05-01 SK SK1591-2001A patent/SK15912001A3/sk unknown
- 2000-05-01 MX MXPA01011286A patent/MXPA01011286A/es unknown
- 2000-05-01 TR TR2001/03286T patent/TR200103286T2/xx unknown
- 2000-05-01 HU HU0201609A patent/HUP0201609A3/hu unknown
- 2000-05-01 CN CNB008071004A patent/CN1145618C/zh not_active Expired - Fee Related
- 2000-05-01 JP JP2000615601A patent/JP2002543193A/ja active Pending
- 2000-05-01 AU AU46886/00A patent/AU766428B2/en not_active Ceased
- 2000-05-01 KR KR1020017013970A patent/KR20010114250A/ko not_active Application Discontinuation
- 2000-05-01 NZ NZ515355A patent/NZ515355A/xx unknown
-
2001
- 2001-11-02 NO NO20015378A patent/NO321361B1/no not_active Application Discontinuation
- 2001-11-02 BG BG106079A patent/BG106079A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20015378D0 (no) | 2001-11-02 |
| EA200101176A1 (ru) | 2002-04-25 |
| KR20010114250A (ko) | 2001-12-31 |
| BR0010213A (pt) | 2002-02-19 |
| CA2371726A1 (en) | 2000-11-09 |
| TR200103286T2 (tr) | 2002-07-22 |
| CZ20013951A3 (cs) | 2002-05-15 |
| IL146280A0 (en) | 2002-07-25 |
| NO20015378L (no) | 2002-01-03 |
| CN1349517A (zh) | 2002-05-15 |
| SK15912001A3 (sk) | 2002-06-04 |
| AU766428B2 (en) | 2003-10-16 |
| HUP0201609A3 (en) | 2002-12-28 |
| MXPA01011286A (es) | 2003-07-14 |
| JP2002543193A (ja) | 2002-12-17 |
| HUP0201609A2 (en) | 2002-08-28 |
| AU4688600A (en) | 2000-11-17 |
| BG106079A (en) | 2002-05-31 |
| SG114650A1 (en) | 2005-09-28 |
| NO321361B1 (no) | 2006-05-02 |
| PL351127A1 (en) | 2003-03-24 |
| CN1145618C (zh) | 2004-04-14 |
| EA004512B1 (ru) | 2004-04-29 |
| EP1173426A1 (en) | 2002-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA72917C2 (en) | Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor | |
| WO2000066564A8 (en) | Benzimidazolones and analogues and their use as progesterone receptor ligands | |
| CY1105688T1 (el) | Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης | |
| NO994452D0 (no) | Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse | |
| ATE194839T1 (de) | Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| AR035548A1 (es) | Compuestos organicos | |
| AR035235A1 (es) | Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento | |
| BR0109855A (pt) | Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5 | |
| AR027402A1 (es) | Derivados de pirimidina. | |
| ES8404990A1 (es) | Un procedimiento para la preparacion de derivados de prolina. | |
| DE60107435D1 (de) | 2-adamantylethylamine und deren verwendung bei der behandlung von abnormalitäten in der glutamat transmission | |
| HUP9901096A2 (hu) | Indolszármazékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0402640A2 (hu) | Indolilalkilamin-származékok 5-hidroxitriptamin-6 ligandumokként, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| BG106080A (en) | Cyclothiocarbamate derivatives as progesterone receptor modulators | |
| PE20020253A1 (es) | Derivados de 3-azabiciclo[3.1.0]hexano como ligandos de receptores opiaceos | |
| DE69811556D1 (de) | Chinoline und Chinazoline Verbindungen und ihre therapeutische Anwendung | |
| NZ515355A (en) | Cyclocarbamate derivatives as progesterone receptor modulators | |
| ES2152379T3 (es) | Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos. | |
| NZ515351A (en) | Thio-oxindole derivatives | |
| GEP20043221B (en) | Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators, Pharmaceutical Composition Containing Them and Use Thereof for Treatment Progesterone-Related Maladies. | |
| HUP0100134A2 (hu) | 1-Metil-5-(alkil-szulfonil/szulfinil vagy tio)-csoporttal szubsztituált pirazolil-pirazol-származékok, előállításuk és alkalmazásuk herbicidként | |
| TWI265032B (en) | Pharmaceutically useful kits comprising progesterone receptor modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| ASS | Change of ownership |
Owner name: WYETH, US Free format text: OLD OWNER(S): WYETH; LIGAND PHARMACEUTICALS INC. |